A
The startup provides cancer immunotherapy services utilizing RNA nanoparticles that instruct the immune system to identify and target cancer cells. This approach enhances the effectiveness of RNA medicines, improving patient immunization and recovery times.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup provides cancer immunotherapy services utilizing RNA nanoparticles that instruct the immune system to identify and target cancer cells. This approach enhances the effectiveness of RNA medicines, improving patient immunization and recovery times.